An increase in plasma levels of angiotensin 1–7 has been observed in SARS-CoV-2-infected individuals (Martins et al., 2021; Miesbach, 2020, suggesting that the Angiotensin 1–7/MASR axis could have a counter-control effect in COVID-19 pathogenesis. This evidence concerns the gene MAS1L and COVID-19.